Similar articles

• Risk of archived resistance after intrapartum nevirapine.

  [No authors listed] [No authors listed] S Afr Med J. 2004 May;94(5):334-5. S Afr Med J. 2004. PMID: 15211942 No abstract available.
• Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial.

  Chi BH, Sinkala M, Mbewe F, Cantrell RA, Kruse G, Chintu N, Aldrovandi GM, Stringer EM, Kankasa C, Safrit JT, Stringer JS. Chi BH, et al. Lancet. 2007 Nov 17;370(9600):1698-705. doi: 10.1016/S0140-6736(07)61605-5. Epub 2007 Nov 7. Lancet. 2007. PMID: 17997151 Clinical Trial.
• Single-dose Nevirapine during pregnancy.

  Sax PE. Sax PE. AIDS Clin Care. 1999 Oct;11(10):84-5. AIDS Clin Care. 1999. PMID: 11366708
• Nevirapine prevents vertical HIV-1 transmission.

  Porche DJ. Porche DJ. J Assoc Nurses AIDS Care. 2000 Jan-Feb;11(1):82-5. doi: 10.1016/S1055-3290(06)60425-1. J Assoc Nurses AIDS Care. 2000. PMID: 10670010 Review. No abstract available.
• HIV-1 drug resistance and mother-to-child transmission.

  Morris L, Pillay C, Gray G, McIntyre J. Morris L, et al. SADJ. 2001 Dec;56(12):614-6. SADJ. 2001. PMID: 11887450 Review.